All tenders
75N93026C00013
TO CONDUCT INVESTIGATIONAL NEW DRUG (IND)-ENABLING STUDIES OF A PRE-CLINICAL CANDIDATE FOR THE TREATMENT OF NEUROTROPIC ALPHAVIRUSES.
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75N93026C00013
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- TO CONDUCT INVESTIGATIONAL NEW DRUG (IND)-ENABLING STUDIES OF A PRE-CLINICAL CANDIDATE FOR THE TREATMENT OF NEUROTROPIC ALPHAVIRUSES.
- Source
- USASpending (Federal)
- Source ID
- usa-75N93026C00013
Details
- Location
- United States
Description
TO CONDUCT INVESTIGATIONAL NEW DRUG (IND)-ENABLING STUDIES OF A PRE-CLINICAL CANDIDATE FOR THE TREATMENT OF NEUROTROPIC ALPHAVIRUSES. Awarded to: UNIVERSITY OF TENNESSEE Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2026/08/03 12:00:00 AM UTC
- Closing date
- 2028/07/31 12:00:00 AM UTC
Estimated value
$1.9M USD
Classification
Normalized category
Healthcare & Medical